LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Oncology Pipeline MacroGenics is actively developing a robust pipeline of antibody-based cancer therapies, presenting opportunities to collaborate on new treatment solutions or expand into additional oncology indications.

Strategic Partnerships With multiple collaborations with leading pharmaceutical and biotech companies, MacroGenics seeks innovative partners, making it a potential target for joint ventures, licensing deals, or co-development projects.

Recent Leadership Growth The appointment of Eric Risser as President and CEO indicates a focus on strategic growth and innovation, signaling potential opportunities for sales teams to align with the company's updated direction or to support their expanding initiatives.

Market Engagements Participation in high-profile investment and healthcare conferences demonstrates MacroGenics' openness to engaging with industry stakeholders, providing opportunities to explore partnership, investment, or supply chain collaborations.

Commercial Product Launch Since launching its first commercial product, Margenza, in 2021, MacroGenics shows ongoing commercial expansion and operational maturity, opening avenues for sales of complementary healthcare products, services, or technological support.

Similar companies to MacroGenics, Inc.

MacroGenics, Inc. Tech Stack

MacroGenics, Inc. uses 8 technology products and services including SAS, Akamai, SQL, and more. Explore MacroGenics, Inc.'s tech stack below.

  • SAS
    Business Intelligence
  • Akamai
    Content Delivery Network
  • SQL
    Database
  • Apple iCloud Mail
    Email
  • Workiva
    Governance, Risk And Compliance
  • Influence Health
    Healthcare Marketing
  • Okta
    Identity Verification
  • Google Analytics
    Web Analytics

Media & News

MacroGenics, Inc.'s Email Address Formats

MacroGenics, Inc. uses at least 1 format(s):
MacroGenics, Inc. Email FormatsExamplePercentage
LastF@macrogenics.comDoeJ@macrogenics.com
83%
Last@macrogenics.comDoe@macrogenics.com
8%
FirstL@macrogenics.comJohnD@macrogenics.com
5%
FLast@macrogenics.comJDoe@macrogenics.com
4%

Frequently Asked Questions

Where is MacroGenics, Inc.'s headquarters located?

Minus sign iconPlus sign iconMacroGenics, Inc.'s main headquarters is located at 9704 Medical Center Drive Rockville, Maryland 20850 United States. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is MacroGenics, Inc.'s phone number?

Minus sign iconPlus sign icon You can contact MacroGenics, Inc.'s main corporate office by phone at
+1-301-251-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is MacroGenics, Inc.'s stock symbol?

Minus sign iconPlus sign iconMacroGenics, Inc. is a publicly traded company; the company's stock symbol is MGNX.

What is MacroGenics, Inc.'s official website and social media links?

Minus sign iconPlus sign iconMacroGenics, Inc.'s official website is macrogenics.com and has social profiles on LinkedInCrunchbase.

How much revenue does MacroGenics, Inc. generate?

Minus sign iconPlus sign icon As of February 2026, MacroGenics, Inc.'s annual revenue is estimated to be $101M.

What is MacroGenics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconMacroGenics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MacroGenics, Inc. have currently?

Minus sign iconPlus sign iconAs of February 2026, MacroGenics, Inc. has approximately 394 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: E. R.Coo: M. R.Chief Scientific Officer: E. B.. Explore MacroGenics, Inc.'s employee directory with LeadIQ.

What industry does MacroGenics, Inc. belong to?

Minus sign iconPlus sign iconMacroGenics, Inc. operates in the Biotechnology Research industry.

What technology does MacroGenics, Inc. use?

Minus sign iconPlus sign iconMacroGenics, Inc.'s tech stack includes SASAkamaiSQLApple iCloud MailWorkivaInfluence HealthOktaGoogle Analytics.

What is MacroGenics, Inc.'s email format?

Minus sign iconPlus sign iconMacroGenics, Inc.'s email format typically follows the pattern of LastF@macrogenics.com. Find more MacroGenics, Inc. email formats with LeadIQ.

How much funding has MacroGenics, Inc. raised to date?

Minus sign iconPlus sign icon As of February 2026, MacroGenics, Inc. has raised $110M in funding. The last funding round occurred on Feb 12, 2019 for $110M.

When was MacroGenics, Inc. founded?

Minus sign iconPlus sign iconMacroGenics, Inc. was founded in 2000.

MacroGenics, Inc.

Biotechnology ResearchMaryland, United States201-500 Employees

MacroGenics is a leader in the discovery and development of innovative medicines that utilize our next generation antibody-based technologies.  Our team of 300+ dedicated individuals is advancing a pipeline of product candidates to treat patients with cancer. Our products and platforms have attracted multiple partnerships with leading pharmaceutical and biotechnology companies around the globe. 
The Company considers its employees to be its most valuable asset and we are committed to providing opportunities for individuals to learn and grow as a means to further their professional development. MacroGenics' corporate culture promotes an atmosphere of innovation, open communication and teamwork where employees can see firsthand how they contribute to the success of the organization.

Section iconCompany Overview

Headquarters
9704 Medical Center Drive Rockville, Maryland 20850 United States
Phone number
+1-301-251-****
Website
macrogenics.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
MGNX
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2000
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $110M

    MacroGenics, Inc. has raised a total of $110M of funding over 10 rounds. Their latest funding round was raised on Feb 12, 2019 in the amount of $110M.

  • $50M$100M

    MacroGenics, Inc.'s revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $110M

    MacroGenics, Inc. has raised a total of $110M of funding over 10 rounds. Their latest funding round was raised on Feb 12, 2019 in the amount of $110M.

  • $50M$100M

    MacroGenics, Inc.'s revenue is estimated to be in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    E. R.
    Chief Executive Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. R.
    Coo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. B.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. W.
    Chief Medical Officer And Senior Vice-President, Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. C.
    Vice President Clinical Operations
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    S. T.
    President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. K.
    President And Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. R.
    Coo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. K.
    President And Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. C.
    Vice President Clinical Operations
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.